SOURCE: GroGenesis, Inc.

GroGenesis, Inc.

October 08, 2015 13:40 ET

GroGenesis Announces New Chairman of the Board of Directors

Experienced Business Veteran in Corporate Governance and Corporate Strategy Joins Restructured Company

SPRINGVILLE, TN--(Marketwired - Oct 8, 2015) - GroGenesis, Inc., (OTCQB: GROG), the rights holder, developer and manufacturer of innovative agricultural enhancement products marketed under the trade names "AgraBurst" and "AgraBlast," announced today the appointment of Grant B. Walsh as a Director and Chairman of the Board of Directors of GroGenesis, effective immediately.

Over the past 30 years, Grant B. Walsh has been chairman and/or director of over twenty companies. Currently, he serves as Chairman of Canada Lands Company Limited (a Canadian Crown Corporation), and as a Director of Medifocus Inc., Square Canada Inc., and Stroud Resources Inc. In addition, Mr. Walsh is the Managing Director of Walsh Delta Group Inc., a firm specializing in leadership, governance, strategy, and performance improvement.

Mr. Walsh has been a CEO, senior executive, chairman and/or director of various U.S. and Canadian companies throughout his career. Focusing on corporate strategy and performance, he has led a number of companies to become high performing organizations.

Mr. Walsh holds a Master of Business Administration (MBA) degree in Finance from Southern Illinois University and a designation as a Chartered Director from McMaster University, Hamilton, Ontario and the Conference Board of Canada. He holds membership in the National Association of Corporate Directors and the Institute of Corporate Directors -- Canada.

Richard Kamolvathin, President and Chief Executive Officer of GroGenesis, stated, "I am truly excited to welcome Grant to GroGenesis. With his in-depth expertise in corporate governance and developing corporate strategies, I look forward to working together to build a ground-breaking agribusiness enterprise and enhancing shareholder value."

Mr. Walsh stated, "It is a distinct honor for me to be associated with Richard Kamolvathin and GroGenesis. Richard is an experienced and very capable executiveOur leadership is strong. Our vision is clear. Our market is global. Richard is committed to lead us in the implementation of strategy to make a difference in sustainable agriculture globally."

Investor Database for Future Press Releases and Industry Updates:
Interested investors and shareholders have the option to sign up to the Company's e-mail database for corporate press releases and periodic industry updates. Or to send a message please visit www.grogenesis.com for more information.

About GroGenesis, Inc.
GroGenesis (OTCQB: GROG) aims to become a leading producer of natural plant growth health technologies. The Company's 'AgraBurst' is a biostimulant blended from processed extracts of natural plant materials that directly improves the positive effects of commercial fertilizers and available nutrients. GroGenesis also offers "AgraBlast" as a companion crop protection product designed as an eco-friendly, non-toxic alternative to synthetic fungicides. When used in combination (as directed), the Company offers an innovative solution for the control of plant pathogenic fungi and for plant remediation and stimulation of yields. Find out more at www.grogenesis.com.

Cautionary Language Concerning Forward-Looking Statements:
This news release contains "forward-looking statements" which are not purely historical. Such forward-looking statements include, among other things, the expectations of management that our technology can successfully commercialized to penetrate our target markets. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits GroGenesis will obtain from them. Actual results could differ from those projected in any forward-looking statements due to numerous factors, including, among others, our inability to commercialize our products successfully, our ability to compete favorably against our competitors who may develop better or cheaper alternatives to our products in the marketplace, our ability to retain key employees and our ability to finance development and operations. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Investors should refer to the risk factors disclosure outlined in our periodic reports filed from time-to-time with the Securities and Exchange Commission.

Contact Information